Neuroscience of addiction

Neuron

Volumn 21, Issue 3, 1998, Pages 467-476

  Koob, George F ^a   Sanna, Pietro Paolo ^a   Bloom, Floyd E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE DERIVATIVE; COCAINE; HYPNOTIC SEDATIVE AGENT; NICOTINE; OPIATE DERIVATIVE; TETRAHYDROCANNABINOL;

DRUG ABUSE; DRUG DEPENDENCE; HUMAN; NEUROBIOLOGY; NEUROPHARMACOLOGY; NEUROSCIENCE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; RELAPSE; REVIEW; WITHDRAWAL SYNDROME;

EID: 0032169803     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80557-7     Document Type: Review

References (85)

1. Aceto, M.D., Scates, S.M., Lowe, J.A., and Martin, B.R. (1995). Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A. Eur. J. Pharmacol. 282, R1-R2.
2. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (Washington, D.C.: American Psychiatric Press).
3. Anthony, J.C., Warner, L.A., and Kessler, R.C. (1994). Comparative epidemiology of dependence on tobacco, ethanol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp. Clin. Psychopharmacol. 2, 244-268.
4. Bailey, C.H., Bartsch, D., and Kandel, E.R. (1996). Toward a molecular definition of long-term memory storage. Proc. Natl. Acad Sci. USA 93, 13445-13452.
5. Gaine, S.B., Heinrichs, S.C., Coffin, V.L., and Koob, G.F. (1995). Effects of the dopamine D1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res. 692, 47-56.
6. Carelli, R.M., and Deadwyler, S.A. (1996). Dual factors controlling activity of nucleus accumbens cell-firing during cocaine self-administration. Synapse 24, 308-311.
7. Chang, J.Y., Sawyer, S.F., Lee, R.-S., and Woodward, D.J. (1994). Electrophysiological and pharmacological evidence for the role of the nucleus accumbens in cocaine self-administration in freely moving rats. J. Neurosci. 14, 1224-1244.
8. Chen, J.P., Paredes, W., Lowinson, J.H., and Gardner, E.L. (1991). Strain-specific facilitation of dopamine efflux by delta 9-tetrahydrocannabinol in the nucleus accumbens of rat: an in vivo microdialysis study. Neurosci. Lett. 129, 136-180.
9. Collins, A.C., Bhat, R.V., Pauly, J.R., and Marks, M.J. (1990). Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists. In The Biology of Nicotine Dependence, G. Bock and J. Marsh, eds. (New York: John Wiley), pp. 87-105.
10. Corrigall, W.A., Franklin, K.B.J., Coen, K.M., and Clarke, P.B.S. (1992). The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107, 285-289.
11. Dani, J.A., and Heinemann, S. (1996). Molecular and cellular aspects of nicotine abuse. Neuron 16, 905-908.
12. Di Chiara, G., and Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85, 5274-5278.
13. Di Chiara, G., and North, R.A. (1992). Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13, 185-193.
14. Diana, M., Pistis, M., Carboni, S., Gessa, G.L., and Rossetti, Z.L. (1993). Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: Electrophysiological and biochemical evidence. Proc. Natl. Acad. Sci USA 90, 7966-7969.
15. Diaz, J., Lévesque, D., Lammers, C.H., Griffon, N., Martres, M.-P., Schwartz, J.-C., and Sokoloff, P. (1995). Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience 65, 731-745.
16. Engel, J.A., Enerback, C., Fahlke, C., Hulthe, P., Hard, E., Johannessen, K., Svensson, L., and Soderpalm, B. (1992). Serotonergic and dopaminergic involvement in ethanol intake. In Novel Pharmacological Interventions for Alcoholism, C.A. Naranjo and E.M. Sellers, eds. (New York: Springer), pp. 68-82.
17. Epping-Jordan, M.P., Markou, A., and Koob, G.F. (1998a). The dopamine D1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reward in the rat. Brain Res. 784, 105-115.
18. Epping-Jordan, M.P., Watkins, S.S., Koob, G.F., and Markou, A. (1998b). Dramatic decreases in brain reward function during nicotine withdrawal. Nature 392, 869-870.
19. Everitt, B.J., Morris, K.A., O'Brien, A., and Robbins, T.W. (1991). The basolateral amygdala-ventral striatal system and conditioned place preference: further evidence of limbic-striatal interactions underlying reward-related processes. Neuroscience 42, 1-18.
20. Gardner, E.L., and Vorel, S.R. (1998). Cannabinoid transmission and reward-related events. Semin. Neurosci., in press.
21. Gardner, E.L., Paredes, W., Smith, D., Donner, A., Milling, C., Cohen, D., and Morrison, D. (1988). Facilitation of brain stimulation reward by delta-9-tetrahydrocannabinol. Psychopharmacology 96, 142-144.
22. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M., and Caron, M.G. (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
23. Headlee, C.P., Coppock, H.W., and Nichols, J.R. (1955). Apparatus and technique involved in a laboratory method of detecting the addictiveness of drugs. J. Am. Pharm. Assoc. Sci. Edn. 44, 229-231.
24. Heimer, L., and Alheid, G. (1991). Piecing together the puzzle of basal forebrain anatomy. In The Basal Forebrain: Anatomy to Function, T.C. Napier, P.W. Kalivas, and I. Hanin, eds. (New York: Plenum Press), pp. 1-42.
25. Henry, D.J., and White, F.J. (1991). Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exp. Ther. 258, 882-890.
26. Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., de Costa, B.R., and Rice, K.C. (1990). Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA 87, 1932-1936.
27. Hope, B.T., Kelz, M.B., Duman, R.S., and Nestler, E.J. (1994). Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J. Neurosci. 14, 4318-4328.
28. Hyman, S.E. (1996). Addiction to cocaine and amphetamine. Neuron 16, 901-904.
29. A receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur. J. Pharmacol. 283, 151-159.
30. Koob, G.F. (1992). Drugs of abuse: anatomy, pharmacology, and function of reward pathways. Trends Pharmacol. Sci. 13, 177-184.
31. Koob, G.F. (1995). Animal models of drug addiction. In Psychopharmacology, The Fourth Generation of Progress, F.E. Bloom and D.J. Kupfer, eds. (New York: Raven Press), pp. 759-772.
32. Koob, G.F. (1996). Drug addiction: the yin and yang of hedonic homeostasis. Neuron 16, 893-896.
33. Koob, G.F., and Bloom, F.E. (1988). Cellular and molecular mechanisms of drug dependence. Science 242, 715-723.
34. Koob, G.F., and Le Moal, M. (1997). Drug abuse: hedonic homeostatic dysregulation. Science 278, 52-58.
35. Koob, G.F., Markou, A., Weiss, F., and Schulteis, G. (1993). Opponent process and drug dependence: neurobiological mechanisms. Semin. Neurosci. 5, 351-358.
36. Koob, G.F., Heinrichs, S.C., Menzaghi, F., Merlo-Pich, E., and Britton, K.T. (1994a). Corticotropin releasing factor, stress and behavior. Semin. Neurosci. 6, 221-229.
37. Koob, G.F., Rassnick, S., Heinrichs, S., and Weiss, F. (1994b). Alcohol, the reward system and dependence. In Toward a Molecular Basis of Alcohol Use and Abuse (Series Title: Experientia Supplementum, Volume 71), B. Jansson, H. Jörnvall, U. Rydberg, L. Terenius, and B.L. Vallee, eds. (Boston: Birkhauser-Verlag), pp. 103-114.
38. Koob, G.F., Carrera, M.R.A., Gold, L.H., Heyser, C.J., Maldonado-Irizarry, C., Markou, A., Parsons, L.H., Roberts, A.J., Schulteis, G., Stinus, L., et al. (1998). Substance dependence as a compulsive behavior. J. Psychopharmacol. 12, 39-48.
39. Kreek, M.J. (1987). Multiple drug abuse patterns and medical consequences. In Psychopharmacology: the Third Generation of Progress, H.Y. Meltzer, ed. (New York: Raven Press), pp. 1597-1604.
40. Lake, J.R., Hebert, K.M., Payza, K., Deshotel, K.D., Hausam, D.D., Witherspoon, W.E., Arcangeli, K.A., and Malin, D.H. (1992). Analog of neuropeptide FF attenuates morphine tolerance. Neurosci. Lett. 146, 203-206.
41. LeMarquand, D., Pihl, R.O., and Benkelfat, C. (1994). Serotonin and ethanol intake, abuse and dependence: findings of animal studies. Biol. Psychiatry 36, 395-421.
42. Le Novere, N., Zoli, M., and Changeux, J.-P. (1996). Neuronal nicotinic receptor α6 subunit mRNA is selectively concentrated in catecholiminergic nuclei of the rat brain. Eur. J. Neurosci. 8, 2428-2439.
43. Lepore, M., Vorel, S.R., Lowinson, J., and Gardner, E.L. (1995). Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. Life Sci. 56, 2073-2080.
44. Lepore, M., Liu, X., Savage, V., Matalon, D., and Gardner, E.L. (1996). Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains. Life Sci. 58, PL365-PL372.
45. Liljequist, S., and Engel, J. (1982). Effects of GABAergic agonists and antagonists on various ethanol-induced behavioral changes. Psychopharmacology 78, 71-75.
46. Maldonado, R., Blendy, J.A., Tzavara, E., Gass, P., Roques, B.P., Hanoune, J., and Schutz, G. (1996). Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273, 657-659.
47. Malin, D.H., Lake, J.R., Hammond, M.V., Fowler, D.E., Rogillio, R.B., Brown, S.L., Sims, J.L., Leecraft, B.M., and Yang, H.-Y.T. (1990). FMRF-NH2-like mammalian octapeptide: possible role in opiate dependence and abstinence. Peptides 11, 969-972.
48. Mansour, A., Watson, S.J., and Akil, H. (1995). Opioid receptors: Past, present and future. Trends Neurosci. 18, 69-70.
49. Matthes, H.W.D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dolle, P., et al. (1996). Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383, 819-823.
50. Merlo-Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G.F., and Weiss, F. (1995). Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15, 5439-5447.
51. Merlo-Pich, E., Pagliusi, S.R., Tessari, M., Talabot-Ayer, D., Hooft van Huijsduijnen, R., and Chiamulera, C. (1997). Common neural substrates for the addictive properties of nicotine and cocaine. Science 275, 83-86.
52. Merue, G., and Gessa, G.L. (1985). Low doses of ethanol inhibit the firing of neurons in the substantia nigra, pars reticulata: a GABAergic effect? Brain Res. 360, 325-330.
53. Negus, S.S., Henriksen, S.J., Mattox, A., Pasternak, G.W., Portoghese, P.S., Takemori, A.E., Weinger, M.B., and Koob, G.F. (1993). Effect of antagonists selective for mu, delta and κ opioid receptors on the reinforcing effects of heroin in rats. J. Pharmacol. Exp. Ther. 265, 1245-1252.
54. Nestler, E.J. (1994). Molecular neurobiology of drug addiction. Neuropsychopharmacology 11, 77-87.
55. Nestler, E.J. (1996). Under siege: the brain on opiates. Neuron 16, 897-900.
56. Olale, F., Gerzanich, V., Kuryatov, R., Wang, F., and Lindstrom, J. (1997). Chronic nicotine exposure differentially affects the function of human α3, α4, and α7 neuronal nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. 283, 675-683.
57. Parsons, L.H., Koob, G.F., and Weiss, F. (1995). Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J. Pharmacol. Exp. Ther. 274, 1182-1191.
58. Peoples, L.L., and West, M.O. (1996). Phasic firing of single neurons in the rat nucleus accumbens correlated with the timing of intravenous cocaine self-administration. J. Neurosci. 16, 3459-3473.
59. Peoples, L.L., Uzwiak, A.J., Gee, F., and West, M.O. (1997). Operant behavior during sessions of intravenous cocaine infusion is necessary and sufficient for phasic firing of single nucleus accumbens neurons. Brain Res. 757, 280-284.
60. Pettit, H.-O., and Justice, J.B., Jr. (1989). Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol. Biochem. Behav. 34, 899-904.
61. Pontieri, F.E., Tanda, G., and Di Chiara, G. (1995). Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. USA 92, 12304-12308.
62. Roberts, A.J., Cole, M., and Koob, G.F. (1996). Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol Clin. Exp. Res. 20, 1289-1298.
63. Roberts, D.C.S., Koob, G.F., Klonoff, P., and Fibiger, H.C. (1980). Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 12, 781-787.
64. Rocha, B.A., Fumagalli, F., Gainetdinov, R.R., Jones, S.R., Ator, R., Giros, B., Miller, G.W., and Caron, M.G. (1998). Cocaine self-administration in dopamine-transporter knockout mice. Nature Neurosci. 1, 132-137.
65. Rodriguez de Fonseca, F., Carrera, M.R.A., Navarro, M., Koob, G.F., and Weiss, F. (1997). Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276, 2050-2054.
66. Rossetti, Z.L., and Carboni, S. (1995). Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur. J. Pharmacol. 283, 177-183.
67. Russell, M.A.M. (1976). What is dependence? In Drugs and Drug Dependence, G. Edwards, M.A.M. Russell, D. Hawks, and M. Mac-Cafferty, eds. (Lexington: MA, Lexington Books), pp. 182-187.
68. Samson, H.H., and Harris, R.A. (1992). Neurobiology of ethanol abuse. Trends Pharmacol. Sci. 13, 206-211.
69. Schuster, C.R., and Thompson, T. (1969). Self-administration of and behavioral dependence on drugs. Annu. Rev. Pharmacol. 9, 483-502.
70. Self, D.W., and Nestler, E.J. (1995). Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18, 463-495.
71. i and Go proteins in nucleus accumbens reduces both cocaine and heroin reinforcement. J. Neurosci. 14, 6239-6247.
72. 2- like dopamine receptor agonists. Science 271, 1586-1589.
73. Sellers, E.M., Higgins, G.A., and Sobell, M.B. (1992). 5-HT and ethanol abuse. Trends Pharmacol. Sci. 13, 69-75.
74. Shippenberg, T.S., Herz, A., Spanagel, R., Bals-Kubik, R., and Stein, C. (1992). Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates. Ann. NY Acad. Sci. 654, 347-356.
75. Stinus, L., Le Moal, M., and Koob, G.F. (1990). Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37, 767-773.
76. Sun, N., and Cassell, M.D. (1993). Intrinsic GABAergic neurons in the rat central extended amygdala. J. Comp. Neurol. 330, 381-404.
77. Tabakoff, B., and Hoffman, P.L. (1996). Alcohol addiction: an enigma among us. Neuron 16, 909-912.
78. Tanda, G., Pontieri, F.E., and Di Chiara, G. (1997a). Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276, 2048-2050.
79. Tanda, G., Pontieri, F.E., Frau, R., and Di Chiara, G. (1997b). Contribution of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur. J. Neurosci. 9, 2077-2085.
80. Volpicelli, J.R., Alterman, A.I., Hayashida, M., and O'Brien, C.P. (1992). Naltrexone in the treatment of ethanol dependence. Arch. Gen. Psychiatry 49, 876-880.
81. Weiss, F., Markou, A., Lorang, M.T., and Koob, G.F. (1992). Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res. 593, 314-318.
82. Weiss, F., Parsons, L.H., Schulteis, G., Hyytia, P., Lorang, M.T., Bloom, F.E., and Koob, G.F. (1996). Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J. Neurosci. 16, 3474-3485.
83. Widnell, K., Self, D.W., Lane, S.B., Russell, D.S., Vaidya, V., Miserendino, M.J.D., Rubin, C.S., Duman, R.S., and Nestler, E.J. (1996). Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens. J. Pharmacol. Exp. Ther. 276, 306-315.
84. Woolverton, W.L., and Johnson, K.M. (1992). Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13, 193-200.
85. Zadina, J.E., Hackler, L., Ge, L.J., and Kastin, A.J. (1997). A potent and selective endogenous agonist for the μ opiate receptor. Nature 386, 499-502.